E2F-4 (RK-13) X Antibody sc-511 X from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

E2F-4 (RK-13) X Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
E2F-4 (RK-13) X Antibody

The E2F-4 (RK-13) X Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to E2F4. This antibody recognizes Homo Sapiens, Human, Mouse, and Rat antigen. The E2F-4 (RK-13) X Antibody has been shown to work in the following applications: Precipitation, Immunofluorescence, Immunohistochemistry - fixed, Immunoprecipitation, and Western Blot.

Product Specs
ItemE2F-4 (RK-13) X Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-511 X
CloneRK-13
Hostmouse
ClonalityMonoclonal
FormatPurified
IsotypeIgG2a
ReactivityHu, Ms, Rt
NCBI Gene AliasesE2F-4, 2010111M04Rik
NCBI Full Gene NameE2F transcription factor 4
ApplicationsWB, IF, IHC-p, IP
Antibody TypePrimary Antibodies
TargetE2F-4
Conjugate/TagUnconjugated
Quantity200 µg/0.1 ml

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) E2F4 regulates cell cycle to mediate embryonic development in pigsTheriogenologyJanuary 15, 2023Jiang WJ, Sun MH, Li XH, Lee SH, Heo G, Zhou D, Cui XS.

(2) Loss of Rbl2 (Retinoblastoma-Like 2) Exacerbates Myocardial Ischemia/Reperfusion InjuryJournal of the American Heart AssociationOctober 4, 2022Chen J, Xia P, Liu Y, Kogan C, Cheng Z.

(3) Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4International journal of biological sciencesJanuary 1, 2022Wei J, Shi Y, Zou C, Zhang H, Peng H, Wang S, Xia L, Yang Y, Zhang X, Liu J, et al.

(4) MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexesCancer lettersJanuary 1, 2018Zhu Y, Gu J, Li Y, Peng C, Shi M, Wang X, Wei G, Ge O, Wang D, Zhang B, et al.

(5) Transforming growth factor β suppresses peroxisome proliferator-activated receptor γ expression via both SMAD binding and novel TGF-β inhibitory elementsThe Biochemical journalApril 24, 2017Lakshmi SP, Reddy AT, Reddy RC.

(6) Development of ultra-super sensitive immunohistochemistry and its application to the etiological study of adult T-cell leukemia/lymphomaActa histochemica et cytochemicaApril 26, 2012Hasui K, Wang J, Tanaka Y, Izumo S, Eizuru Y, Matsuyama T.

(7) Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cellsMolecular cancerOctober 14, 2010Li Y, Yuan YY, Meeran SM, Tollefsbol TO.

(8) E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllinInternational journal of cancerNovember 1, 2009Chimploy K, Díaz GD, Li Q, Carter O, Dashwood WM, Mathews CK, Williams DE, Bailey GS, Dashwood RH.

(9) Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxiaOncogeneMarch 29, 2007Bindra RS, Glazer PM.

(10) Transactivation of E2F-regulated genes by polyomavirus large T antigen: evidence for a two-step mechanismMolecular and cellular biologyDecember 1, 2004Nemethova M, Smutny M, Wintersberger E.

(11) HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathwayOncogeneJune 17, 2004Finzer P, Krueger A, Stöhr M, Brenner D, Soto U, Kuntzen C, Krammer PH, Rösl F.

(12) Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F functionThe EMBO journalNovember 1, 2002Schlisio S, Halperin T, Vidal M, Nevins JR.

(13) SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cellsBiochemical pharmacologyOctober 1, 2002Yu B, Lane ME, Wadler S.

(14) Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycleThe Journal of biological chemistryAugust 30, 2002Ambrosino C, Palmieri C, Puca A, Trimboli F, Schiavone M, Olimpico F, Ruocco MR, di Leva F, Toriello M, Quinto I, et al.

(15) Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skinOncogeneOctober 29, 1998Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ.

Be the First to Write a Review!